GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Metropolis Healthcare Ltd (BOM:542650) » Definitions » ROE %

Metropolis Healthcare (BOM:542650) ROE % : 10.60% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Metropolis Healthcare ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Metropolis Healthcare's annualized net income for the quarter that ended in Dec. 2024 was ₹1,254 Mil. Metropolis Healthcare's average Total Stockholders Equity over the quarter that ended in Dec. 2024 was ₹11,839 Mil. Therefore, Metropolis Healthcare's annualized ROE % for the quarter that ended in Dec. 2024 was 10.60%.

The historical rank and industry rank for Metropolis Healthcare's ROE % or its related term are showing as below:

BOM:542650' s ROE % Range Over the Past 10 Years
Min: 12.26   Med: 27.55   Max: 33.78
Current: 13.73

During the past 9 years, Metropolis Healthcare's highest ROE % was 33.78%. The lowest was 12.26%. And the median was 27.55%.

BOM:542650's ROE % is ranked better than
86.96% of 207 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.93 vs BOM:542650: 13.73

Metropolis Healthcare ROE % Historical Data

The historical data trend for Metropolis Healthcare's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metropolis Healthcare ROE % Chart

Metropolis Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE %
Get a 7-Day Free Trial Premium Member Only 27.03 29.77 26.89 15.25 12.26

Metropolis Healthcare Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.38 13.29 13.85 15.72 10.60

Competitive Comparison of Metropolis Healthcare's ROE %

For the Diagnostics & Research subindustry, Metropolis Healthcare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Metropolis Healthcare's ROE % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Metropolis Healthcare's ROE % distribution charts can be found below:

* The bar in red indicates where Metropolis Healthcare's ROE % falls into.


;
;

Metropolis Healthcare ROE % Calculation

Metropolis Healthcare's annualized ROE % for the fiscal year that ended in Mar. 2024 is calculated as

ROE %=Net Income (A: Mar. 2024 )/( (Total Stockholders Equity (A: Mar. 2023 )+Total Stockholders Equity (A: Mar. 2024 ))/ count )
=1278.162/( (9882.323+10961.555)/ 2 )
=1278.162/10421.939
=12.26 %

Metropolis Healthcare's annualized ROE % for the quarter that ended in Dec. 2024 is calculated as

ROE %=Net Income (Q: Dec. 2024 )/( (Total Stockholders Equity (Q: Sep. 2024 )+Total Stockholders Equity (Q: Dec. 2024 ))/ count )
=1254.42/( (11839.431+0)/ 1 )
=1254.42/11839.431
=10.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2024) net income data. ROE % is displayed in the 30-year financial page.


Metropolis Healthcare  (BOM:542650) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=1254.42/11839.431
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(1254.42 / 12910.696)*(12910.696 / 16312.289)*(16312.289 / 11839.431)
=Net Margin %*Asset Turnover*Equity Multiplier
=9.72 %*0.7915*1.3778
=ROA %*Equity Multiplier
=7.69 %*1.3778
=10.60 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=1254.42/11839.431
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (1254.42 / 1693.424) * (1693.424 / 1772.504) * (1772.504 / 12910.696) * (12910.696 / 16312.289) * (16312.289 / 11839.431)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7408 * 0.9554 * 13.73 % * 0.7915 * 1.3778
=10.60 %

Note: The net income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Metropolis Healthcare ROE % Related Terms

Thank you for viewing the detailed overview of Metropolis Healthcare's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Metropolis Healthcare Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, 4th Floor, East Wing, Plot-254 B, Nirlon House, Worli, Mumbai, MH, IND, 400 030
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.

Metropolis Healthcare Headlines

No Headlines